Product Name: Human CEACAM5 / CEA / CD66e Antibody (Immunomedics patent anti-CEACAM5 (Class III), Research Use)
Catalog Number: NBR-0948
Target Name: CEACAM5 / CEA / CD66e
Trade Name: Immunomedics patent anti-CEACAM5 (Class III)
Antibody Drug Description: The drug is a recombinant fully human anti-CEACAM5 monoclonal antibody, being developed by Immunomedics. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD66a
Synonyms: BGP; BGP1; CD66a
Target Description: CEACAM1 (CEA Cell Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with CEACAM1 include Acute Gonococcal Endometritis and Adenomatoid Tumor. Among its related pathways are Innate Immune System and Cell surface interactions at the vascular wall. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity. An important paralog of this gene is CEACAM5.
Ensembl: ENSG00000079385
Uniprot: P13688